Double Triggering Asynchrony in Mechanically Ventilated Patients.

April 10, 2026 updated by: Mansoura University

Sensitivity of Diaphragmatic Ultrasonography in Detecting Double Triggering Asynchrony in Mechanically Ventilated ICU Patients.

This observational study examined double triggering asynchrony in28ICU patients on mechanical ventilation. Researchers collected data on patient characteristics, health conditions, and outcomes to understand how this problem affects critically ill patients. Findings may help improve ventilator care in intensive care units.

Study Overview

Study Type

Observational

Enrollment (Actual)

28

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Dakahlia Governorate
      • Al Mansurah, Dakahlia Governorate, Egypt, 35516
        • Specialised Medical Hospital - ICU

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Adult patients (>18 years) admitted to medical/surgical ICU at Specialized Medical Hospital, Mansoura University, receiving invasive mechanical ventilation with documented double triggering asynchrony on ventilator waveform analysis.

Description

Inclusion Criteria:

  • Adult ICU patients aged ≥18 years receiving invasive mechanical ventilation
  • Documented double triggering asynchrony on ventilator waveform analysis.

Exclusion Criteria:

  • Patients with contraindications to diaphragmatic ultrasound, including thoracic or abdominal surgery.
  • Patients with known diseases affecting diaphragmatic function, such as Duchenne muscular dystrophy (DMD) or myasthenia gravis (MG).
  • Patients with advanced chronic liver disease (Child-Pugh class C)
  • Patients with chronic increased intra-abdominal pressure.
  • Patients with moderate to massive pleural effusion.
  • Patient or legal guardian refusal to participate in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Double Triggering Cohort
28mechanically ventilated ICU patients identified with double triggering asynchrony

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sensitivity of diaphragmatic ultrasound for detection of double triggering asynchrony
Time Frame: During ICU admission, at the time of double triggering detection by ventilator graph interpretation
Proportion of double triggering asynchrony events correctly identified by diaphragmatic ultrasound compared with ventilator waveform analysis as the reference standard
During ICU admission, at the time of double triggering detection by ventilator graph interpretation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 5, 2024

Primary Completion (Actual)

October 20, 2025

Study Completion (Actual)

November 2, 2025

Study Registration Dates

First Submitted

January 17, 2026

First Submitted That Met QC Criteria

January 24, 2026

First Posted (Actual)

February 2, 2026

Study Record Updates

Last Update Posted (Actual)

April 15, 2026

Last Update Submitted That Met QC Criteria

April 10, 2026

Last Verified

December 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Critical Illness

Subscribe